Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Career Feature
  • Published:

Career feature

Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development

Nature Biotechnology volume 40, pages 1528–1529 (2022)Cite this article

Subjects

Developing a device development educational core will further enhance national, international and multidisciplinary innovation and collaboration in the biomedical device domain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Translational pathway for cardiovascular devices.
Fig. 2: 2021–2022 Translational Pathways for Cardiovascular Devices course registration data.

References

  1. Sullivan, T. The significant physician contribution to the development of medical devices. Policy & Medicine (May); https://www.policymed.com/2013/10/the-significant-physician-contribution-to-the-development-of-medical-devices.html (2018).

  2. Langin, K. Science https://doi.org/10.1126/science.caredit.aax3138 (2019).

    Article  PubMed  Google Scholar 

  3. Xu, H., Gilliam, R. S. T., Peddada, S. D., Buchold, G. M. & Collins, T. R. L. Nat. Biotechnol. 36, 197–202 (2018).

    Article  CAS  Google Scholar 

  4. Kahn, S. & Ginther, D. K. Nat. Biotechnol. 35, 90–94 (2017).

    Article  CAS  Google Scholar 

  5. Fayolle, A. & Gailly, B. J. Small Bus. Manag. 53, 75–93 (2015).

    Article  Google Scholar 

  6. Niccum, B. A., Sarker, A., Wolf, S. J. & Trowbridge, M. J. Med. Educ. Online 22, 1360722 (2017).

    Article  Google Scholar 

  7. Anonymous. Why do 75% of U.S. based medical device start-ups fail? Proximo (July); https://proximomedical.com/why-do-75-of-u-s-based-medical-device-start-ups-fail/ (2019).

  8. Anonymous. What is the medical device development process (includes stages). TWI; https://www.twi-global.com/technical-knowledge/faqs/what-is-the-medical-device-development-process (2022).

  9. Anonymous. Cardiovascular devices market size is prognosticated to reach USD 86.27 billion by 2028, exhibiting a CAGR of 6.9%. Fortune Business Insights (September); https://www.globenewswire.com/en/news-release/2021/09/06/2291732/0/en/Cardiovascular-Devices-Market-Size-Is-Prognosticated-to-Reach-USD-86-27-Billion-by-2028-Exhibiting-a-CAGR-of-6-9.html (2021).

  10. Elliott, C., Mavriplis, C. & Anis, H. Intl Entrep. Manag. J. 16, 43–67 (2020).

    Article  Google Scholar 

  11. International Society for Cardiovascular Translational Research. Translational Pathways for Cardiovascular Devices; https://isctr.org/online-course-translational-pathways-for-cardiovascular-devices/ (2021).

  12. Zalaznick, M. Tech transfer: Ranking the top 25 research universities in the U.S. University Business (May); https://universitybusiness.com/tech-transfer-ranking-the-top-25-research-universities-heartland-forward/ (2022).

Download references

Acknowledgements

The authors received funding from the Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation (DK 119114), the Clinical and Translational Science Award (TR001445) and the Short-Term Research Training Grant for Medical Students (DK007421).

Author information

Authors and Affiliations

  1. New York University Grossman School of Medicine, New York, New York, USA

    Gabriel Vizgan, Zachary Hill-Whilton, Colleen Gillespie, Daniel Cobos & Gabrielle Gold-von Simson

  2. SUNY Downstate College of Medicine, Brooklyn, New York, USA

    Gabriel Vizgan

  3. International Society for Cardiovascular Translational Research, Phoenix, Arizona, USA

    LeAnn Johnson & Nabil Dib

Authors
  1. Gabriel Vizgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zachary Hill-Whilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Colleen Gillespie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Cobos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. LeAnn Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nabil Dib
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabrielle Gold-von Simson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriel Vizgan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vizgan, G., Hill-Whilton, Z., Gillespie, C. et al. Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development. Nat Biotechnol 40, 1528–1529 (2022). https://doi.org/10.1038/s41587-022-01498-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01498-6

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing